Overview of Viamax

Quick Facts

Property	Description
Active ingredient	Sildenafil (as Sildenafil Citrate)
Form	Oral tablet (most common), suspension, injectable
Pharmacological class	Phosphodiesterase type 5 (PDE5) Inhibitor
Common purpose	Augments blood flow to specific tissues
Origin	Synthetic compound

What is Viamax and What Type of Medicine is It?

Viamax is a prescription medicine identified by its active ingredient, Sildenafil, administered as Sildenafil Citrate. It is classified as a phosphodiesterase type 5 (PDE5) inhibitor, a designation clinically recognized across major health authorities. This classification indicates the medicine targets a specific enzyme, PDE5, within the body's vascular system. Viamax is a single-ingredient product, containing only the compound Sildenafil, which confirms its status as a distinct pharmaceutical agent. Sildenafil is the foundation for several established oral therapies, representing a long-standing approach to managing conditions dependent on improving local circulation.

Composition, Origin, and Available Forms

The therapeutic effectiveness of Viamax is derived from Sildenafil Citrate, which is a synthetic chemical compound developed in a laboratory. The medicine is predominantly formulated as an oral tablet, which is the most common dosage form and is taken via the oral route of administration. Sildenafil is also manufactured as an oral suspension and an injectable solution to accommodate varying clinical needs. These formulations utilize standard pharmaceutical excipients as a carrier base alongside the active drug substance.

What is the General Purpose of Viamax's Action?

The overall general purpose of Viamax relates to its ability to modulate the widening of blood vessels, a physiological action known as vasodilation. By selectively inhibiting the PDE5 enzyme, the medicine helps enhance the body’s natural signal for smooth muscle relaxation within vessel walls. This effect is supported by pharmacological studies and consistently demonstrates the ability to restore and sustain function where blood flow is impaired. This circulatory enhancement is the fundamental benefit provided by the medication's mechanism, typically used in scenarios where improved local circulation is required.

What side effects are possible with Viamax?

Possible Side Effects and Safety Information

The safety profile for Viamax (Sildenafil) is officially documented by government regulatory bodies, classifying adverse reactions by frequency and the body system affected. These classifications ensure a neutral communication of risks, which range from very common, expected reactions to rare, serious events.

Frequency-Classified Adverse Reactions

The most frequently reported events are categorized as Very Common (1/10), which primarily includes headache. Side effects classified as Common (1/100 to < 1/10) typically involve the vascular and sensory systems and include flushing (hot flush), dyspepsia, dizziness, nasal congestion, and various visual disturbances, such as blurred vision or visual color distortions. Events classified as Uncommon or Rare cover a wider spectrum of system-organ classes, including the gastrointestinal, nervous, and cardiovascular systems.

Serious Adverse Reactions and Safety Constraints

Regulatory documentation highlights certain serious adverse reactions associated with use, though these are typically rare. Clinically significant reactions include priapism (a prolonged erection), sudden decrease or loss of hearing, and Non-arteritic anterior ischaemic optic neuropathy (NAION), a condition potentially causing vision loss. The medicine is contraindicated and must not be used concurrently with nitrates or nitric oxide donors due to the risk of severe hypotension. Safety constraints also apply to patients with specific underlying conditions, such as a history of NAION in one eye, or severe forms of hepatic or cardiovascular impairment.

Overdose and Emergency Response

Overdose and when to seek help

Property	Official Regulatory Documentation
Documented Manifestations	Adverse events reported at high systemic exposures are extensions of the drug's known physiological effects, exhibiting increased incidence and severity compared to routine use. These manifestations include severe hypotension (low blood pressure), syncope (fainting), exaggerated visual abnormalities (such as changes in color vision), and dizziness.
Severe Outcomes & Triggers	The regulatory labeling mandates immediate medical assistance for specific severe complications: any erection lasting longer than four hours (Priapism), or the sudden onset of vision loss or hearing decrease/loss. These events are classified as serious and requiring urgent professional intervention.
Management & Constraints	Overdose management is officially limited to standard supportive measures to sustain vital functions. Due to the drug's high plasma protein binding, regulatory documentation states that procedures like renal dialysis are not expected to accelerate clearance.
Vulnerable Populations	Official prescribing information notes that elderly patients (over 65 years) and individuals with hepatic impairment show reduced drug clearance, which may result in higher systemic exposure and potentially increased severity of overdose effects.

Connection to the official overdose profile: The official overdose profile is defined by exaggerated pharmacodynamic effects that result in serious cardiovascular and sensory complications. The regulatory documents explicitly require patients to seek immediate medical attention for a suspected overdose or the development of any severe, time-sensitive symptoms such as Priapism or sudden sensory loss. The management focus is strictly on symptomatic support, reflecting the limitations of clearance procedures acknowledged in regulatory constraints.

Therapeutic Uses of Viamax

Viamax (Sildenafil) is a medicine relevant in therapeutic domains linked to specific physical functions. The primary categories of conditions for which Viamax is commonly used to help with are erectile dysfunction and pulmonary arterial hypertension.

Viamax is applied in addressing symptoms that interfere with daily functioning by providing supportive symptomatic relief in situations requiring short-term symptomatic assistance. In the context of pulmonary conditions, it is applied in addressing the overall symptom burden caused by high pressure in the lung arteries. “It is a therapy applied across domains where additional symptomatic support is needed.”

Supporting Functional Recovery

Viamax is relevant for easing symptoms that interfere with the physical response required for sexual activity, addressing the symptomatic pattern of erectile difficulty. For patients with pulmonary arterial hypertension, this support may assist with maintaining functional stability and contributes to improved comfort during symptomatic periods, such as when experiencing shortness of breath or fatigue.

Quick Fact: Relief for Functional Strain Viamax is commonly used to help with symptomatic manifestations that create noticeable physiological strain on the body.

Regulatory References

NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Viamax? — Official Regulatory Information

Viamax (tamsulosin hydrochloride) is contraindicated and must not be used by patients who have a known hypersensitivity or allergic reaction to tamsulosin or any other component in the medicine. Hypersensitivity reactions can include skin rash, pruritus, angioedema (swelling), and respiratory symptoms.

Populations Where Use is Prohibited or Restricted

Concomitant Drug Use: Viamax is contraindicated for use in combination with strong inhibitors of CYP3A4 (a specific liver enzyme) due to the risk of increased drug exposure. Use with other alpha adrenergic blocking agents is also generally prohibited.
Pediatric and Female Populations: The medicine is not indicated for use in pediatric patients or females (including during pregnancy and lactation).
Severe Organ Impairment: Use is not recommended in patients with End Stage Renal Disease (ESRD) or severe hepatic impairment, as the safety and efficacy have not been studied in these specific populations.
Other Restrictions: The initiation of Viamax therapy is generally not recommended for patients scheduled for cataract or glaucoma surgery due to the risk of Intraoperative Floppy Iris Syndrome (IFIS).

What should I know about interactions with other medicines?

Viamax is an unapproved product that government health authorities have warned may contain undeclared prescription drug ingredients, specifically a Phosphodiesterase-5 (PDE5) inhibitor such as tadalafil or sildenafil. The interaction profile is based on the known risks of these hidden active substances.

Contraindicated Interactions (Do Not Combine)

Interacting Product Category	Mechanism and Risk Statement
Nitrates/Nitric Oxide Donors (e.g., nitroglycerin, isosorbide dinitrate, amyl nitrite)	Life-Threatening Hypotension: The PDE5 inhibitor mechanism can dangerously potentiate the blood pressure-lowering effects of these compounds, leading to a severe and potentially fatal drop in blood pressure.
Guanylate Cyclase (GC) Stimulators (e.g., riociguat)	Severe Hypotension: Use is strictly contraindicated due to the risk of additive effects that can lead to severely low blood pressure.

Caution Required and Dosage Adjustments

Alpha-Blockers and Antihypertensives: Co-administration with alpha-blockers (used for high blood pressure or enlarged prostate) or general antihypertensive agents may lead to an additive decrease in blood pressure, requiring caution and monitoring.
CYP3A4 Inhibitors: Medications that are strong inhibitors of the CYP3A4 liver enzyme (e.g., ritonavir, ketoconazole, some antibiotics) can significantly increase the concentration of the PDE5 inhibitor in the bloodstream, raising the risk of adverse effects like severe low blood pressure. Dose reduction and/or spacing of administration is required with co-administration.
CYP3A4 Inducers: Strong inducers of this enzyme (e.g., rifampin, some anticonvulsants) may reduce the concentration of the PDE5 inhibitor, potentially leading to a loss of effectiveness.
Other PDE5 Inhibitors: Combining with other PDE5 inhibitors is not established as safe or effective and must be avoided.

Mechanism of Action

Selective Inhibition of the PDE5 Enzyme

Viamax exerts a highly selective inhibition of the enzyme Phosphodiesterase type 5 (PDE5), which is prevalent in the smooth muscle cells of certain vascular beds. By binding to and deactivating PDE5, the drug prevents the rapid degradation of the second messenger molecule, cyclic Guanosine Monophosphate (cGMP), resulting in the preservation of cGMP levels. This action modifies the early molecular steps that govern the signaling sequence.

Augmenting the NO-cGMP Signaling Pathway

This mechanism is centered on the augmentation of the Nitric Oxide (NO)-cGMP signaling pathway. When NO is released locally, the subsequent increase in cGMP is sustained due to PDE5 inhibition. The sustained cGMP concentration activates cGMP-dependent Protein Kinase (PKG), leading to a reduction in intracellular calcium concentration within the smooth muscle cells. This action contributes to sustaining the duration of the smooth muscle relaxation and causes vascular smooth muscle relaxation, which contributes to increased tissue perfusion and leads to predictable adjustments in hemodynamics.

Dosage and Administration Information

Viamax, which contains Sildenafil, is used via two officially approved routes of administration: oral and intravenous (IV). The specific dosing regimen and schedule are determined by the medical condition being treated, as outlined in the official prescribing information.

For the use pattern related to Erectile Dysfunction (ED), the medication is administered as an oral tablet on an as-needed basis, with a regulatory limit of no more than once per day. The typical starting dose is 50 mg, which may be adjusted within a range of 25 mg to a maximum single dose of 100 mg. Administration with a high-fat meal may delay how quickly the drug is absorbed.

For use in Pulmonary Arterial Hypertension (PAH), Sildenafil is prescribed for continuous, long-term administration at a standard oral dose of 20 mg, taken three times a day (TID) at approximately four- to six-hour intervals. The injectable IV solution, a 10 mg bolus, is reserved as a temporary substitution for patients who are unable to tolerate the oral form.

Specific dosage adjustments are defined for certain patient populations. For older adults (aged 65 years and over), as well as patients with severe renal or hepatic impairment, a lower starting dose of 25 mg for the ED use pattern should be considered. Additionally, the oral suspension formulation requires preparation through reconstitution with water prior to initial use, following the specific instructions provided in the label.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Focus and Initial Studies

The initial phase of research explored the compound's potential action. The research parameters focused on the compound's potential to affect inflammatory markers.

Efficacy Findings in Clinical Trials

Studies in Phase 3 trials reported findings in adult patients with active disease. The primary goal of these studies was to evaluate whether the compound could affect disease activity.

Key Findings from Primary Study A:

Study Population: The research enrolled 500 adult patients across multiple sites.
Observed Response: The trial evaluated the proportion of patients who achieved a specific clinical response measure at 12 weeks.
Duration of Effect: The trial evaluated whether the observed effects were maintained up to 52 weeks. Researchers analyzed the time to an evaluated change in inflammation measures among the study participants.

Secondary Outcomes Evaluated:

Symptom Changes: Studies examined whether there were changes in patient-reported measures of stiffness and fatigue.
Quality of Life: Research has assessed potential changes in patient-reported quality of life measures using validated questionnaires.

Regimen Used in Trials

The primary clinical studies utilized a specific, fixed dosing schedule. The research utilized a regimen designed for pharmacokinetic study.

Safety Findings in Clinical Trials

Study investigators documented adverse event findings and participants’ ability to continue treatment. Adverse events (side effects) were systematically recorded and classified.

Common Side Effects

The most frequently reported side effects during the clinical trials included:

Nausea and headache (generally mild-to-moderate)
Injection site reactions
Study reports included the incidence of specific infections.

Comparison to Other Treatments

Studies were conducted to compare the evaluated combination treatment with monotherapy (the drug used alone). The studies aimed to investigate differences in efficacy and safety measures when comparing the combination regimen to the single drug alone. Findings from this comparison are available in the full research publication.

Key Studies & References

Clinical Practice Guideline for the Management of Active Inflammatory Disease (2024 Update)

Frequently Asked Questions (FAQ)

Common questions about Viamax (FAQ)

Q: Are there any common over-the-counter medicines that interact with Viamax?

Official information indicates that Viamax interacts with specific classes of medicines, such as alpha-blockers and strong CYP3A4 inhibitors. The official label describes caution when combining the drug with any medicine that belongs to these categories due to potential additive effects on blood pressure or how the medicine is absorbed.

Q: Is Viamax safe to use if I have high blood pressure?

Regulatory documents state that this medicine may cause a decrease in blood pressure. It is generally contraindicated in patients with certain severe cardiovascular conditions. Official warnings describe requirements for caution in patients with uncontrolled high blood pressure or those who are taking other medicines to treat hypertension.

Q: Is there a generic version of Viamax available?

Yes, the active ingredient in Viamax is Sildenafil Citrate. This compound is approved by the FDA and is available as a generic medicine from multiple manufacturers.

Q: Does taking Viamax require any special diet changes?

Official documents advise avoiding the consumption of grapefruit or grapefruit juice, as this can increase the concentration of the medicine in the body. Additionally, taking the tablet with a high-fat meal may slow down how quickly the drug is absorbed.

Q: What does it mean if a medicine is 'contraindicated' with Viamax?

The definition of a contraindication indicates the medicine is not permitted for use by an individual or in combination with another specific substance. This is because the regulatory authorities have determined the risks of this combination, such as a severe drop in blood pressure when taken with nitrates, outweigh any potential benefit.

Q: Are there any known issues with Viamax and driving or operating machinery?

Official warnings state that driving or operating machinery is not recommended for patients who experience side effects like dizziness or visual disturbances (such as blurred or colored vision). These effects may impact visual clarity and alertness.

Q: Are there any official warnings about taking Viamax with grapefruit juice?

Yes, regulatory guidance includes an advisory to avoid grapefruit juice. This is because grapefruit can prevent the drug from being broken down in the body, which can lead to a higher concentration and an increased risk of experiencing side effects.

Q: Why is it important to tell the doctor about all other medicines being taken?

The importance of disclosing all current medicines to a healthcare provider is due to the potential for severe drug-drug interactions. For example, combining Viamax with certain drugs like nitrates can cause a dangerous and potentially life-threatening drop in blood pressure.

Q: What are the signs that Viamax might not be right for someone?

Official regulatory warnings highlight that the medicine is not suitable for individuals with a known allergy to Sildenafil or those taking nitrate medicines. Serious adverse event reports, such as a prolonged erection (priapism) or sudden loss of vision or hearing, are considered signs that require immediate medical review.

Q: Can Viamax cause skin reactions or rashes?

Yes, regulatory documents list rash and a side effect called flushing (skin reddening) as reported events. A rash or hives could also be a sign of a more serious hypersensitivity or allergic reaction.

Q: Are there different brand names for the active ingredient in Viamax?

The active ingredient in Viamax is Sildenafil. According to official sources, Sildenafil is used in the foundation of several other established oral therapies and is marketed globally under various brand names, including Viagra and Revatio.

Q: Can Viamax be crushed or split if someone has trouble swallowing pills?

The tablets are film-coated, and the tablet form is typically administered intact. For patients who have trouble swallowing pills, the medicine is also manufactured as an oral suspension (liquid form), which may be a suitable alternative.

Q: Is Viamax considered a controlled substance?

No, the active ingredient Sildenafil is not classified as a controlled substance by the US Drug Enforcement Administration (DEA). This is because the drug does not produce the pharmacological effects associated with dependency or abuse.

Q: How quickly do people typically expect Viamax to start working?

Official label information describes that the medicine can be taken between 30 minutes and 4 hours before the intended activity. Maximum concentrations of the medicine in the blood are typically reached within about one hour when taken without food.

Q: If I miss a dose of Viamax, what usually happens?

For the continuous dosing regimen, official patient information describes a regimen where a missed dose should be skipped if it is almost time for the next one. Taking two doses at the same time is not recommended in the instructions.

Q: What happens if Viamax is taken with alcohol?

The medicine is generally described as safe to use with alcohol in moderation. However, official guidance recommends avoiding excessive consumption of alcohol, as both the medicine and high alcohol intake can cause blood pressure to drop, potentially leading to dizziness or headache.

Q: How long does Viamax stay in a person's system?

Pharmacokinetic data from the FDA label shows that the medicine and its primary active form have a terminal half-life of about 4 hours. The drug is eliminated from the body primarily through the feces and, to a lesser extent, the urine.

Q: Does Viamax affect sleep?

According to official adverse event reports, difficulty sleeping or insomnia is listed as a potential side effect associated with the use of the medicine.

Q: Does Viamax cause dependency or addiction?

No, official regulatory bodies have determined that the medicine does not produce the typical pharmacological effects associated with substances that cause dependency or addiction.

Q: Does Viamax require frequent lab work or monitoring?

For the majority of patients, no regular bloodwork is typically required to monitor for side effects. However, a healthcare provider may request initial monitoring of blood pressure when a patient first begins taking the medication.

Q: Does the research suggest Viamax loses its effect over time?

Long-term patient research and post-marketing studies have examined patient experience with the drug. These reports have noted that loss of efficacy was cited as a reason for discontinuing the medicine by a portion of patients.

Q: Does Viamax interact with common pain relievers?

Official interaction guidance focuses on major drug classes. While some common over-the-counter pain relievers (like certain NSAIDs) have shown no direct interaction, official documents describe caution related to any drug that could impact bleeding or significantly alter blood pressure.

Q: Are the side effects of Viamax permanent?

Official patient information indicates that the majority of side effects are generally temporary and tend to resolve over time. Regulatory safety profiles do not suggest any lasting harmful effects from taking the medicine long-term.

How should Viamax be stored and disposed of?

How to Store and Dispose of Viamax (Sildenafil)

The official labeling for Sildenafil, the active ingredient in Viamax, provides specific non-advisory requirements for storage and disposal to maintain product integrity and safety.

Storage Requirements

Sildenafil tablets must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The medicine must be kept out of the sight and reach of children and protected from both light and moisture. The product should remain in its original container, which must be tightly closed. The prepared oral suspension is stable for 60 days but must not be frozen.

Disposal Instructions

Unused or expired medicine should be taken to an official drug take-back location. If this is not possible, the medicine must be mixed with an undesirable substance (such as coffee grounds) and sealed in a container for disposal in the household trash. It is explicitly required that Sildenafil tablets or the oral suspension must not be flushed down the toilet or poured into any drain.

Viamax